Correlation Between Akari Therapeutics and IBio, Common

Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and IBio, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and IBio, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akari Therapeutics PLC and iBio, Common Stock, you can compare the effects of market volatilities on Akari Therapeutics and IBio, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of IBio, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and IBio, Common.

Diversification Opportunities for Akari Therapeutics and IBio, Common

-0.31

Correlation Coefficient

Akari Therapeutics  IBio, Common

Very good diversification

The 3 months correlation between Akari and IBio, is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and iBio, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iBio, Common Stock and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with IBio, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iBio, Common Stock has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and IBio, Common go up and down completely randomly.

Pair Corralation between Akari Therapeutics and IBio, Common

Given the investment horizon of 90 days Akari Therapeutics is expected to generate 1.55 times less return on investment than IBio, Common. In addition to that, Akari Therapeutics is 1.08 times more volatile than iBio, Common Stock. It trades about 0.1 of its total potential returns per unit of risk. iBio, Common Stock is currently generating about 0.17 per unit of volatility. If you would invest  245.00  in iBio, Common Stock on December 27, 2024 and sell it today you would earn a total of  196.00  from holding iBio, Common Stock or generate 80.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Akari Therapeutics PLC  vs.  iBio, Common Stock

Akari Therapeutics PLC

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Akari Therapeutics PLC are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Akari Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

iBio, Common Stock

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in iBio, Common Stock are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, IBio, Common displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Akari Therapeutics and IBio, Common

The main advantage of trading using opposite Akari Therapeutics and IBio, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, IBio, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IBio, Common will offset losses from the drop in IBio, Common's long position.

The idea behind Akari Therapeutics PLC and iBio, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.